R Châtel

465 total citations
22 papers, 352 citations indexed

About

R Châtel is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, R Châtel has authored 22 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in R Châtel's work include Blood Pressure and Hypertension Studies (6 papers), Hormonal Regulation and Hypertension (3 papers) and Sodium Intake and Health (2 papers). R Châtel is often cited by papers focused on Blood Pressure and Hypertension Studies (6 papers), Hormonal Regulation and Hypertension (3 papers) and Sodium Intake and Health (2 papers). R Châtel collaborates with scholars based in Hungary, Switzerland and Belgium. R Châtel's co-authors include P Weidmann, François C. Reubi, C Beretta-Piccoli, Walter Ziegler, Josef Flammer, W. Vetter, Miklós Tóth, I Forgács, Katalin Sz. Szalay and Mathias Schmid and has published in prestigious journals such as Kidney International, The American Journal of Medicine and The American Journal of Cardiology.

In The Last Decade

R Châtel

22 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Châtel Hungary 9 149 119 73 65 57 22 352
B Łacka Poland 10 144 1.0× 146 1.2× 63 0.9× 54 0.8× 99 1.7× 24 424
M.G.A. Baggen Netherlands 10 84 0.6× 96 0.8× 34 0.5× 109 1.7× 35 0.6× 25 356
Jack G. Silah Canada 7 125 0.8× 163 1.4× 49 0.7× 108 1.7× 97 1.7× 9 404
Mauro Rathaus Israel 11 95 0.6× 41 0.3× 79 1.1× 48 0.7× 41 0.7× 17 343
Miriam Parker United States 7 242 1.6× 88 0.7× 197 2.7× 63 1.0× 78 1.4× 10 435
Elisabeth C. Samouilidou Greece 12 80 0.5× 62 0.5× 102 1.4× 27 0.4× 40 0.7× 26 372
Naoko Deji Japan 6 44 0.3× 97 0.8× 86 1.2× 32 0.5× 66 1.2× 14 343
Bruno Sevá Pessôa Netherlands 7 143 1.0× 104 0.9× 24 0.3× 31 0.5× 100 1.8× 8 322
Ichiyu Shou Japan 11 78 0.5× 39 0.3× 178 2.4× 49 0.8× 37 0.6× 27 337
Maria G. Dekker Canada 9 134 0.9× 201 1.7× 239 3.3× 28 0.4× 70 1.2× 9 474

Countries citing papers authored by R Châtel

Since Specialization
Citations

This map shows the geographic impact of R Châtel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Châtel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Châtel more than expected).

Fields of papers citing papers by R Châtel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Châtel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Châtel. The network helps show where R Châtel may publish in the future.

Co-authorship network of co-authors of R Châtel

This figure shows the co-authorship network connecting the top 25 collaborators of R Châtel. A scholar is included among the top collaborators of R Châtel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Châtel. R Châtel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Göőz, Mónika, Miklós Tóth, Olli Vakkuri, et al.. (2004). Endogenous ouabain-like factor (OLF) secretion is modulated by nicotinic mechanisms in rat adrenocortical cells. Life Sciences. 74(17). 2111–2128. 5 indexed citations
2.
Reginster, Jean‐Yves, R Lorenc, Tim D. Spector, et al.. (2003). Strontium ranelate reduces the risk of non vertebral fractures in women with postmenopausal osteoporosis. Osteoporosis International. 14. 2 indexed citations
3.
Göőz, Mónika, Olli Vakkuri, R Châtel, Katalin Sz. Szalay, & Miklós Tóth. (2003). Elevated Blood Levels of Endogenous Ouabain-Like Factor in Preterm versus Mature Newborns at Birth. Neonatology. 85(3). 155–158. 2 indexed citations
4.
Meunier, Pierre J., R Lorenc, Ian Smith, et al.. (2002). Strontium ranelate: new efficient anti-osteoporotic agent for treatment of vertebral osteoporosis in postmenopausal women. Open Repository and Bibliography (University of Liège). 7 indexed citations
5.
Demeter, Judit, et al.. (2001). Familial occurrence of the May-Hegglin anomaly: is the accompanying renal failure part of a new subentity?. Annals of Hematology. 80(6). 368–371. 2 indexed citations
6.
Porzsolt, Franz, et al.. (2000). P53 mutations in hairy cell leukemia. Leukemia. 14(4). 706–711. 27 indexed citations
7.
Szalay, Katalin Sz., et al.. (1998). Interactions between ouabain, atrial natriuretic peptide, angiotensin-II and potassium: Effects on rat zona glomerulosa aldosterone production. Life Sciences. 62(20). 1845–1852. 13 indexed citations
8.
Welker, Horst A., et al.. (1998). Pharmacokinetics and Pharmacodynamics of Mibefradil in Hypertensive Patients with Varying Degrees of Renal Insufficiency. Pharmacology. 56(6). 297–307. 2 indexed citations
9.
Tislér, András, István Barna, & R Châtel. (1994). [Comparative study of 24-hour ambulatory blood pressure monitors with standard zero and random zero sphygmomanometers].. PubMed. 135(26). 1415–9. 4 indexed citations
10.
Châtel, R, Miklós Tóth, István Barna, & András Tislér. (1992). Body sodium, atrial natriuretic peptide and blood pressure in diabetes mellitus.. PubMed. 63(1-2). 153–61. 1 indexed citations
11.
Châtel, R, et al.. (1991). Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis. International Urology and Nephrology. 23(2). 177–183. 8 indexed citations
12.
Földes, J., et al.. (1987). Urinary 6-Keto-Prostaglandin F1α(6-keto-PGF1α) Excretion and its Relation to Plasma Renin Activity in Hyperthyroidism. Hormone and Metabolic Research. 19(12). 667–668. 1 indexed citations
13.
Eppley, Robert M., Mary W Trucksess, Stanley Nesheim, et al.. (1986). Thin Layer Chromatographic Method for Determination of Deoxynivalenol in Wheat: Collaborative Study. Journal of AOAC INTERNATIONAL. 69(1). 37–40. 12 indexed citations
14.
Weidmann, P, R Châtel, Walter Ziegler, Josef Flammer, & François C. Reubi. (1978). Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. The American Journal of Cardiology. 41(3). 570–576. 27 indexed citations
15.
Châtel, R, P Weidmann, Josef Flammer, et al.. (1977). Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus. Kidney International. 12(6). 412–421. 155 indexed citations
16.
Beretta-Piccoli, C, P Weidmann, R Châtel, & François C. Reubi. (1976). Hypertension associated with early stage kidney disease. The American Journal of Medicine. 61(5). 739–747. 52 indexed citations
17.
Forgács, I, et al.. (1969). The effect of hypertonic sodium chloride infused into the renal artery.. PubMed. 35(3). 219–29. 4 indexed citations
18.
Forgács, I, et al.. (1968). Renal function in water deprivation.. PubMed. 33(3). 297–304. 3 indexed citations
19.
Châtel, R, et al.. (1965). Renal circulation and baroreceptor reflexes.. PubMed. 28(4). 363–71. 1 indexed citations
20.
Bálint, P, R Châtel, Ágnes Fekete, & I Forgács. (1964). HAEMODYNAMICS AND OXYGEN CONSUMPTION OF THE KIDNEY IN POST-ISCHAEMIC RENAL FAILURE.. PubMed. 26. 471–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Łacka Breakdown of academic impact, for papers by M.G.A. Baggen Breakdown of academic impact, for papers by Jack G. Silah Breakdown of academic impact, for papers by Mauro Rathaus Breakdown of academic impact, for papers by Miriam Parker Breakdown of academic impact, for papers by Elisabeth C. Samouilidou Breakdown of academic impact, for papers by Naoko Deji Breakdown of academic impact, for papers by Bruno Sevá Pessôa Breakdown of academic impact, for papers by Ichiyu Shou Breakdown of academic impact, for papers by Maria G. Dekker
Rankless by CCL
2026